Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07665827Not ApplicableNot Yet Recruiting

Efficacy and Safety of Antihypertensive Treatment With Mobile Stroke Units in Ultra-Early Intracerebral Hemorrhage

Role: collaborator

NCT06943885Not ApplicableRecruiting

Comparison of 5G-Mobile Stroke Unit With Standard EMS for Acute Ischemic Stroke

Role: lead

NCT03926325Unknown

Baseline Investigation of Patients With Cardiac Arrest in China

Role: collaborator

NCT04275349Unknown

Trial of pRehospital Intervention With trAditional Chinese Medicine for Acute strokE

Role: collaborator

NCT02728180Phase 4Unknown

Xingnaojing for Moderate-to-severe Acute Ischemic Stroke (XMAS)

Role: collaborator

NCT02645877Completed

Trends of the Pre-hospital Emergency Care Spectrum in Beijing From 2005 to 2014: A Retrospective Analysis

Role: collaborator

All 6 trials loaded